Shionogi Inc patents expiration
1. Doribax patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5317016 | SHIONOGI INC | Pyrrolidylthiocarbapenem derivative |
Jun, 2015
(8 years ago) | |
| US8247402 | SHIONOGI INC | Crystal form of pyrrolidylthiocarbapenem derivative |
Mar, 2021
(3 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Oct 12, 2012 |
Drugs and Companies using DORIPENEM ingredient
NCE-1 date: 13 October, 2011
Market Authorisation Date: 05 October, 2010
Treatment: Method of treating bacterial infections
Dosage: INJECTABLE;INTRAVENOUS
DORIBAX family patents
2. Fetroja patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US9238657 | SHIONOGI INC | Cephalosporin having catechol group |
Nov, 2033
(9 years from now) | |
| US10004750 | SHIONOGI INC | Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof |
Sep, 2035
(11 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9949982 | SHIONOGI INC | Preparation containing cephalosporin having a catechol moiety |
Sep, 2035
(11 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Nov 14, 2024 |
| Generating Antibiotic Incentives Now(GAIN) | Nov 14, 2029 |
| New Indication(I-844) | Sep 25, 2023 |
Drugs and Companies using CEFIDEROCOL SULFATE TOSYLATE ingredient
NCE-1 date: 14 November, 2028
Market Authorisation Date: 14 November, 2019
Treatment: Method of treating hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (habp/vabp) comprising administering cefiderocol sulfate tosylate
Dosage: POWDER;INTRAVENOUS
FETROJA family patents
3. Rybix Odt patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5464632 | SHIONOGI INC | Rapidly disintegratable multiparticular tablet |
Mar, 2013
(11 years ago) | |
| US6106861 | SHIONOGI INC | Multiparticulate tablet disintegrating in less than 40 seconds in the mouth |
Dec, 2017
(6 years ago) | |
Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient
Market Authorisation Date: 05 May, 2005
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
RYBIX ODT family patents
4. Ulesfia patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5858383 | SHIONOGI INC | Methods and compositions for topical treatment of ectoparasites |
Aug, 2017
(6 years ago) | |
| US6139859 | SHIONOGI INC | Methods and compositions for topical treatment of ectoparasites |
Aug, 2017
(6 years ago) | |
| US6793931 | SHIONOGI INC | Ectoparasite asphyxiator compositions and methods for their applications |
Jul, 2022
(1 year, 9 months ago) | |
| US7294342 | SHIONOGI INC | Ectoparasite asphyxiator compositions and methods for their application |
May, 2024
(29 days from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Apr 09, 2014 |
Drugs and Companies using BENZYL ALCOHOL ingredient
NCE-1 date: 09 April, 2013
Market Authorisation Date: 09 April, 2009
Treatment: Topical treatment of lice infestations
Dosage: LOTION;TOPICAL
ULESFIA family patents